Scholarlink

Background <p>The hybrid EMT state is a key driver of tumour regenerative and metastatic potential; however, the mechanism whereby this programme regulates tumour stemness with respect to self-renewal and differentiation remains unclear.</p> Methods <p>We isolated epithelial/mesenchymal (E/M) (CD104<sup>high</sup>CD44<sup>high</sup>) and mesenchymal (M) (CD104<sup>low</sup> CD44<sup>high</sup>) subpopulations from basal-like breast cancer cell lines. These were assayed for tumour-initiating potential and organoid-forming ability, as well as for transcriptional regulators of the hybrid EMT state by RNA and ATAC-sequencing, and their regulation by the Wnt/ERK/CDK4/6 signalling pathway.</p> Results <p>E/M cells were endowed with organoid-forming ability as well as by tumour-initiating and metastatic potential relative to M cells. Interestingly, Wnt3a stimulates <i>transient</i> ERK/CDK4/6 activation in E/M cells, thereby upregulating FOXC2, and in turn TAp63 and ΔNp63, which support the hybrid state. In parallel, ERK/CDK4/6 activates S-phase and FOXM1, thereby promoting self-renewal. Remarkably, transient ERK activation by Wnt3a deactivates EGFR, thus preventing sustained ERK phosphorylation from causing E/M differentiation. Consistently, ERK/CDK4/6 drug perturbation in E/M cells suppressed FOXC2/p63, FOXM1, self-renewal, organoid formation and mammary tumour growth via epithelial differentiation.</p> Conclusions <p>These findings unravelled a mechanism whereby the hybrid EMT state regulates stemness, self-renewal and differentiation via transient Wnt/ERK/CDK4/6 activation, which can be leveraged for cancer stem cell therapy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Wnt/ERK/CDK4/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月24日

查看全文
  • Huizhi Liang,
  • Outhiriaradjou Benard,
  • Viney Kumar,
  • Anthony Griffen,
  • Zuen Ren,
  • Kalaiselvi Sivalingam,
  • Jingli Wang,
  • Elena de Simone Benito,
  • Xusheng Zhang,
  • Jinghang Zhang,
  • Kimita Suyama,
  • Lindsay M. LaFave,
  • Larry Norton,
  • Rachel B. Hazan

摘要

Background

The hybrid EMT state is a key driver of tumour regenerative and metastatic potential; however, the mechanism whereby this programme regulates tumour stemness with respect to self-renewal and differentiation remains unclear.

Methods

We isolated epithelial/mesenchymal (E/M) (CD104highCD44high) and mesenchymal (M) (CD104low CD44high) subpopulations from basal-like breast cancer cell lines. These were assayed for tumour-initiating potential and organoid-forming ability, as well as for transcriptional regulators of the hybrid EMT state by RNA and ATAC-sequencing, and their regulation by the Wnt/ERK/CDK4/6 signalling pathway.

Results

E/M cells were endowed with organoid-forming ability as well as by tumour-initiating and metastatic potential relative to M cells. Interestingly, Wnt3a stimulates transient ERK/CDK4/6 activation in E/M cells, thereby upregulating FOXC2, and in turn TAp63 and ΔNp63, which support the hybrid state. In parallel, ERK/CDK4/6 activates S-phase and FOXM1, thereby promoting self-renewal. Remarkably, transient ERK activation by Wnt3a deactivates EGFR, thus preventing sustained ERK phosphorylation from causing E/M differentiation. Consistently, ERK/CDK4/6 drug perturbation in E/M cells suppressed FOXC2/p63, FOXM1, self-renewal, organoid formation and mammary tumour growth via epithelial differentiation.

Conclusions

These findings unravelled a mechanism whereby the hybrid EMT state regulates stemness, self-renewal and differentiation via transient Wnt/ERK/CDK4/6 activation, which can be leveraged for cancer stem cell therapy.